Murphy, Middleton, Hinkle & Parker, Inc. Novartis Ag Transaction History
Murphy, Middleton, Hinkle & Parker, Inc.
- $172 Million
- Q2 2024
A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 1,966 shares of NVS stock, worth $225,048. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,966Holding current value
$225,048% of portfolio
0.12%Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.4 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.39 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$849 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$848 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$681 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $246B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...